Table of Content

1. Introduction


2. Research & Methodology


3. Executive Summary


4. Market Dynamics

4.1 Growth Drivers
4.2 Challenges


5. Global Cystic Fibrosis Therapeutics Market


6. Market Share – Global Cystic Fibrosis Therapeutics Market

6.1 By Route of Administration
6.2 By Treatment Method
6.3 By Test Type
6.4 By Distribution Channels
6.5 By Drug Class
6.6 By Region


7. Route of Administration – Global Cystic Fibrosis Therapeutics Market

7.1 Oral
7.2 Inhale


8. Treatment Method – Global Cystic Fibrosis Therapeutics Market

8.1 Medication
8.2 Devices
8.3 Other Treatment


9. Test Type – Global Cystic Fibrosis Therapeutics Market

9.1 Pulmonary Function Test
9.2 Sweat Test
9.3 IRT Test
9.4 Fecal Tests
9.5 Genetic Tests


10. Distribution Channels – Global Cystic Fibrosis Therapeutics Market

10.1 Hospitals
10.2 Retail Pharmacies
10.3 Others


11. Drug Class – Global Cystic Fibrosis Therapeutics Market

11.1 Pancreatic Enzyme Supplements Drug
11.2 Mucolytics Drug
11.3 Bronchodilators Drug
11.4 CFTR Modulators Drug


12. Region – Global Cystic Fibrosis Therapeutics Market

12.1 North America
12.2 Europe
12.3 Asia Pacific
12.4 Latin America
12.5 Middle East & Africa


13. Company Insights

13.1 Vertex Pharmaceuticals

13.1.1 Overview
13.1.2 Recent Development
13.1.3 Revenue

13.2 Abbvie Inc.

13.2.1 Overview
13.2.2 Recent Development
13.2.3 Revenue

13.3 Novartis Ag

13.3.1 Overview
13.3.2 Recent Development
13.3.3 Revenue

13.4 Gilead Sciences

13.4.1 Overview
13.4.2 Recent Development
13.4.3 Revenue

13.5 Viatris INC

13.5.1 Overview
13.5.2 Recent Development
13.5.3 Revenue

13.6 Pfizer

13.6.1 Overview
13.6.2 Recent Development
13.6.3 Revenue

13.7 Astrazeneca

13.7.1 Overview
13.7.2 Recent Development
13.7.3 Revenue



List of Figures

Figure-01: Global – Cystic Fibrosis Therapeutics Market (Billion US$), 2016 – 2022
Figure-02: Global – Forecast for Cystic Fibrosis Therapeutics Market (Billion US$), 2023 – 2028
Figure-03: Route of Administration – Oral Market (Million US$), 2016 – 2022
Figure-04: Route of Administration – Forecast for Oral Market (Million US$), 2023 – 2028
Figure-05: Route of Administration – Inhale Market (Million US$), 2016 – 2022
Figure-06: Route of Administration – Forecast for Inhale Market (Million US$), 2023 – 2028
Figure-07: Treatment Method – Medication Market (Million US$), 2016 – 2022
Figure-08: Treatment Method – Forecast for Medication Market (Million US$), 2023 – 2028
Figure-09: Treatment Method – Devices Market (Million US$), 2016 – 2022
Figure-10: Treatment Method – Forecast for Devices Market (Million US$), 2023 – 2028
Figure-11: Treatment Method – Other Treatment Market (Million US$), 2016 – 2022
Figure-12: Treatment Method – Forecast for Other Treatment Market (Million US$), 2023 – 2028
Figure-13: Test Type – Pulmonary Function Test Market (Million US$), 2016 – 2022
Figure-14: Test Type – Forecast for Pulmonary Function Test Market (Million US$), 2023 – 2028
Figure-15: Test Type – Sweat Test Market (Million US$), 2016 – 2022
Figure-16: Test Type – Forecast for Sweat Test Market (Million US$), 2023 – 2028
Figure-17: Test Type – IRT Test Market (Million US$), 2016 – 2022
Figure-18: Test Type – Forecast for IRT Test Market (Million US$), 2023 – 2028
Figure-19: Test Type – Fecal Tests Market (Million US$), 2016 – 2022
Figure-20: Test Type – Forecast for Fecal Tests Market (Million US$), 2023 – 2028
Figure-21: Test Type – Genetic Tests Market (Million US$), 2016 – 2022
Figure-22: Test Type – Forecast for Genetic Tests Market (Million US$), 2023 – 2028
Figure-23: Distribution Channels – Hospitals Market (Million US$), 2016 – 2022
Figure-24: Distribution Channels – Forecast for Hospitals Market (Million US$), 2023 – 2028
Figure-25: Distribution Channels – Retail Pharmacies Market (Million US$), 2016 – 2022
Figure-26: Distribution Channels – Forecast for Retail Pharmacies Market (Million US$), 2023 – 2028
Figure-27: Distribution Channels – Others Market (Million US$), 2016 – 2022
Figure-28: Distribution Channels – Forecast for Others Market (Million US$), 2023 – 2028
Figure-29: Drug Class – Pancreatic Enzyme Supplements Drug Market (Million US$), 2016 – 2022
Figure-30: Drug Class – Forecast for Pancreatic Enzyme Supplements Drug Market (Million US$), 2023 – 2028
Figure-31: Drug Class – Mucolytics Drug Market (Million US$), 2016 – 2022
Figure-32: Drug Class – Forecast for Mucolytics Drug Market (Million US$), 2023 – 2028
Figure-33: Drug Class – Bronchodilators Drug Market (Million US$), 2016 – 2022
Figure-34: Drug Class – Forecast for Bronchodilators Drug Market (Million US$), 2023 – 2028
Figure-35: Drug Class – CFTR Modulators Drug Market (Million US$), 2016 – 2022
Figure-36: Drug Class – Forecast for CFTR Modulators Drug Market (Million US$), 2023 – 2028
Figure-37: North America – Cystic Fibrosis Therapeutics Market (Million US$), 2016 – 2022
Figure-38: North America – Forecast for Cystic Fibrosis Therapeutics Market (Million US$), 2023 – 2028
Figure-39: Europe – Cystic Fibrosis Therapeutics Market (Million US$), 2016 – 2022
Figure-40: Europe – Forecast for Cystic Fibrosis Therapeutics Market (Million US$), 2023 – 2028
Figure-41: Asia Pacific – Cystic Fibrosis Therapeutics Market (Million US$), 2016 – 2022
Figure-42: Asia Pacific – Forecast for Cystic Fibrosis Therapeutics Market (Million US$), 2023 – 2028
Figure-43: Latin America – Cystic Fibrosis Therapeutics Market (Million US$), 2016 – 2022
Figure-44: Latin America – Forecast for Cystic Fibrosis Therapeutics Market (Million US$), 2023 – 2028
Figure-45: Middle East & Africa – Cystic Fibrosis Therapeutics Market (Million US$), 2016 – 2022
Figure-46: Middle East & Africa – Forecast for Cystic Fibrosis Therapeutics Market (Million US$), 2023 – 2028
Figure-47: Vertex Pharmaceuticals – Global Revenue (Billion US$), 2016 – 2022
Figure-48: Vertex Pharmaceuticals – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-49: Abbvie Inc. – Global Revenue (Billion US$), 2016 – 2022
Figure-50: Abbvie Inc. – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-51: Novartis Ag – Global Revenue (Billion US$), 2016 – 2022
Figure-52: Novartis Ag – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-53: Gilead Sciences – Global Revenue (Billion US$), 2016 – 2022
Figure-54: Gilead Sciences – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-55: Viatris INC – Global Revenue (Billion US$), 2016 – 2022
Figure-56: Viatris INC – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-57: Pfizer – Global Revenue (Billion US$), 2016 – 2022
Figure-58: Pfizer – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-59: Astrazeneca – Global Revenue (Billion US$), 2016 – 2022
Figure-60: Astrazeneca – Forecast for Global Revenue (Billion US$), 2023 – 2028

List of Tables

Table-01: Global – Cystic Fibrosis Therapeutics Market Share by Route of Administration (Percent), 2016 – 2022
Table-02: Global – Forecast for Cystic Fibrosis Therapeutics Market Share by Route of Administration (Percent), 2023 – 2028
Table-03: Global – Cystic Fibrosis Therapeutics Market Share by Treatment Method (Percent), 2016 – 2022
Table-04: Global – Forecast for Cystic Fibrosis Therapeutics Market Share by Treatment Method (Percent), 2023 – 2028
Table-05: Global – Cystic Fibrosis Therapeutics Market Share by Test Type (Percent), 2016 – 2022
Table-06: Global – Forecast for Cystic Fibrosis Therapeutics Market Share by Test Type (Percent), 2023 – 2028
Table-07: Global – Cystic Fibrosis Therapeutics Market Share by Distribution Channels (Percent), 2016 – 2022
Table-08: Global – Forecast for Cystic Fibrosis Therapeutics Market Share by Distribution Channels (Percent), 2023 – 2028
Table-09: Global – Cystic Fibrosis Therapeutics Market Share by Drug Class (Percent), 2016 – 2022
Table-10: Global – Forecast for Cystic Fibrosis Therapeutics Market Share by Drug Class (Percent), 2023 – 2028
Table-11: Global – Cystic Fibrosis Therapeutics Market Share by Region (Percent), 2016 – 2022
Table-12: Global – Forecast for Cystic Fibrosis Therapeutics Market Share by Regions(Percent), 2023 – 2028